Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 135

1.

Patients' and clinicians' perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care.

Cooke AC, Knight KR, Miaskowski C.

Int J Drug Policy. 2019 Jan;63:23-28. doi: 10.1016/j.drugpo.2018.09.002. Epub 2018 Nov 23.

PMID:
30472467
2.

Risk Factors for Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis.

Gordon SM, Stitt RS, Nee R, Bailey WT, Little DJ, Knight KR, Hughes JB, Edison JD, Olson SW.

J Rheumatol. 2019 Jan;46(1):85-92. doi: 10.3899/jrheum.171186. Epub 2018 Jul 15.

PMID:
30008456
3.

ZnO Nanoparticles Protect RNA from Degradation Better than DNA.

McCall J, Smith JJ, Marquardt KN, Knight KR, Bane H, Barber A, DeLong RK.

Nanomaterials (Basel). 2017 Nov 8;7(11). pii: E378. doi: 10.3390/nano7110378.

4.

Differential toxicity and venom gland gene expression in Centruroides vittatus.

McElroy T, McReynolds CN, Gulledge A, Knight KR, Smith WE, Albrecht EA.

PLoS One. 2017 Oct 4;12(10):e0184695. doi: 10.1371/journal.pone.0184695. eCollection 2017.

5.

Opioid pharmacovigilance: A clinical-social history of the changes in opioid prescribing for patients with co-occurring chronic non-cancer pain and substance use.

Knight KR, Kushel M, Chang JS, Zamora K, Ceasar R, Hurstak E, Miaskowski C.

Soc Sci Med. 2017 Aug;186:87-95. doi: 10.1016/j.socscimed.2017.05.043. Epub 2017 May 23.

6.

Diabetic nephropathy as the cause of end-stage kidney disease reported on the medical evidence form CMS2728 at a single center.

Yuan CM, Nee R, Ceckowski KA, Knight KR, Abbott KC.

Clin Kidney J. 2017 Apr;10(2):257-262. doi: 10.1093/ckj/sfw112. Epub 2016 Dec 22.

7.

Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy (ACCL05C1): A Report From the Children's Oncology Group.

Knight KR, Chen L, Freyer D, Aplenc R, Bancroft M, Bliss B, Dang H, Gillmeister B, Hendershot E, Kraemer DF, Lindenfeld L, Meza J, Neuwelt EA, Pollock BH, Sung L.

J Clin Oncol. 2017 Feb;35(4):440-445. doi: 10.1200/JCO.2016.69.2319. Epub 2016 Dec 12.

8.

Teaching Structure: A Qualitative Evaluation of a Structural Competency Training for Resident Physicians.

Neff J, Knight KR, Satterwhite S, Nelson N, Matthews J, Holmes SM.

J Gen Intern Med. 2017 Apr;32(4):430-433. doi: 10.1007/s11606-016-3924-7. Epub 2016 Nov 28.

9.

Provider Experiences With the Identification, Management, and Treatment of Co-occurring Chronic Noncancer Pain and Substance Use in the Safety Net.

Chang JS, Kushel M, Miaskowski C, Ceasar R, Zamora K, Hurstak E, Knight KR.

Subst Use Misuse. 2017 Jan 28;52(2):251-255. Epub 2016 Oct 18.

10.

Evaluation and Management of Hearing Loss in Survivors of Childhood and Adolescent Cancers: A Report From the Children's Oncology Group.

Bass JK, Knight KR, Yock TI, Chang KW, Cipkala D, Grewal SS.

Pediatr Blood Cancer. 2016 Jul;63(7):1152-62. doi: 10.1002/pbc.25951. Epub 2016 Feb 29. Review.

11.

Risk factors for stimulant use among homeless and unstably housed adult women.

Riley ED, Shumway M, Knight KR, Guzman D, Cohen J, Weiser SD.

Drug Alcohol Depend. 2015 Aug 1;153:173-9. doi: 10.1016/j.drugalcdep.2015.05.023. Epub 2015 May 27.

12.

Syndemic vulnerability, sexual and injection risk behaviors, and HIV continuum of care outcomes in HIV-positive injection drug users.

Mizuno Y, Purcell DW, Knowlton AR, Wilkinson JD, Gourevitch MN, Knight KR.

AIDS Behav. 2015 Apr;19(4):684-93. doi: 10.1007/s10461-014-0890-0.

13.

Recent violence in a community-based sample of homeless and unstably housed women with high levels of psychiatric comorbidity.

Riley ED, Cohen J, Knight KR, Decker A, Marson K, Shumway M.

Am J Public Health. 2014 Sep;104(9):1657-63. doi: 10.2105/AJPH.2014.301958. Epub 2014 Jul 17.

14.

Single room occupancy (SRO) hotels as mental health risk environments among impoverished women: the intersection of policy, drug use, trauma, and urban space.

Knight KR, Lopez AM, Comfort M, Shumway M, Cohen J, Riley ED.

Int J Drug Policy. 2014 May;25(3):556-61. doi: 10.1016/j.drugpo.2013.10.011. Epub 2013 Nov 8.

15.

A roadmap for adapting an evidence-based HIV prevention intervention: personal cognitive counseling (PCC) for episodic substance-using men who have sex with men.

Knight KR, Das M, DeMicco E, Raiford JL, Matheson T, Shook A, Antunez E, Santos GM, Dadasovich R, Dilley JW, Colfax GN, Herbst JH.

Prev Sci. 2014 Jun;15(3):364-75. doi: 10.1007/s11121-013-0364-z.

16.

Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.

Brock PR, Knight KR, Freyer DR, Campbell KC, Steyger PS, Blakley BW, Rassekh SR, Chang KW, Fligor BJ, Rajput K, Sullivan M, Neuwelt EA.

J Clin Oncol. 2012 Jul 1;30(19):2408-17. doi: 10.1200/JCO.2011.39.1110. Epub 2012 Apr 30. Review.

17.

Agents of change: peer mentorship as HIV prevention among HIV-positive injection drug users.

Mackenzie S, Pearson C, Frye V, Gómez CA, Latka MH, Purcell DW, Knowlton AR, Metsch LR, Tobin KE, Valverde EE, Knight KR.

Subst Use Misuse. 2012 Apr;47(5):522-34. doi: 10.3109/10826084.2012.644122.

PMID:
22428820
18.

Pancreatic islet transplantation using vascularised chambers containing nerve growth factor ameliorates hyperglycaemia in diabetic mice.

Hussey AJ, Winardi M, Wilson J, Forster N, Morrison WA, Penington AJ, Knight KR, Feeney SJ.

Cells Tissues Organs. 2010;191(5):382-93. doi: 10.1159/000276595. Epub 2010 Jan 14.

19.

Sarcopenia--mechanisms and treatments.

Jones TE, Stephenson KW, King JG, Knight KR, Marshall TL, Scott WB.

J Geriatr Phys Ther. 2009;32(2):83-9. Review. Erratum in: J Geriatr Phys Ther. 2009;32(3):110.

PMID:
20039588
20.

Cell therapy for diabetes: stem cells, progenitors or beta-cell replication?

Gonez LJ, Knight KR.

Mol Cell Endocrinol. 2010 Jul 8;323(1):55-61. doi: 10.1016/j.mce.2009.12.014. Epub 2009 Dec 21. Review.

PMID:
20026173
21.

Seeding of pancreatic islets into prevascularized tissue engineering chambers.

Hussey AJ, Winardi M, Han XL, Thomas GP, Penington AJ, Morrison WA, Knight KR, Feeney SJ.

Tissue Eng Part A. 2009 Dec;15(12):3823-33. doi: 10.1089/ten.TEA.2008.0682.

PMID:
19558221
22.

Retraction. The role of biological extracellular matrix scaffolds in vascularized three-dimensional tissue growth in vivo.

Cronin KJ, Messina A, Thompson EW, Morrison WA, Stevens GW, Knight KR.

J Biomed Mater Res B Appl Biomater. 2009 May;89(2):575. doi: 10.1002/jbm.b.31268. No abstract available.

PMID:
19301286
23.

Vascularized tissue-engineered chambers promote survival and function of transplanted islets and improve glycemic control.

Knight KR, Uda Y, Findlay MW, Brown DL, Cronin KJ, Jamieson E, Tai T, Keramidaris E, Penington AJ, Rophael J, Harrison LC, Morrison WA.

FASEB J. 2008 Oct;22(10):3747. doi: 10.1096/fj.05-4879fjeerr. No abstract available.

PMID:
18827031
24.

Predictors of current housing status among HIV-seropositive injection drug users (IDUs): results from a 1-year study.

Mizuno Y, Purcell DW, Zhang J, Knowlton AR, De Varona M, Arnsten JH, Knight KR.

AIDS Behav. 2009 Feb;13(1):165-72. doi: 10.1007/s10461-008-9364-6. Epub 2008 Feb 5.

PMID:
18247113
25.

Sexual transmission risk behavior reported among behaviorally bisexual HIV-positive injection drug-using men.

Knight KR, Shade SB, Purcell DW, Rose CD, Metsch LR, Latka MH, Latkin CA, Gómez CA; INSPIRE Study Team.

J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S80-7. doi: 10.1097/QAI.0b013e3181576828.

PMID:
18089988
26.

Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users.

Arnsten JH, Li X, Mizuno Y, Knowlton AR, Gourevitch MN, Handley K, Knight KR, Metsch LR; INSPIRE Study Team.

J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S64-71. doi: 10.1097/QAI.0b013e31815767d6.

PMID:
18089986
27.

Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users.

Purcell DW, Latka MH, Metsch LR, Latkin CA, Gómez CA, Mizuno Y, Arnsten JH, Wilkinson JD, Knight KR, Knowlton AR, Santibanez S, Tobin KE, Rose CD, Valverde EE, Gourevitch MN, Eldred L, Borkowf CB; INSPIRE Study Team.

J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S35-47. doi: 10.1097/QAI.0b013e31815767c4.

PMID:
18089983
28.

Intimate partner violence perpetration against main female partners among HIV-positive male injection drug users.

Frye V, Latka MH, Wu Y, Valverde EE, Knowlton AR, Knight KR, Arnsten JH, O'Leary A; INSPIRE Study Team.

J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S101-9. doi: 10.1097/QAI.0b013e31815767e6.

PMID:
18089979
29.

Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.

Jahnke K, Kraemer DF, Knight KR, Fortin D, Bell S, Doolittle ND, Muldoon LL, Neuwelt EA.

Cancer. 2008 Feb 1;112(3):581-8.

30.
31.

Survival and differentiation of pituitary colony-forming cells in vivo.

Lepore DA, Thomas GP, Knight KR, Hussey AJ, Callahan T, Wagner J, Morrison WA, Thomas PQ.

Stem Cells. 2007 Jul;25(7):1730-6. Epub 2007 Mar 29.

32.

The role of biological extracellular matrix scaffolds in vascularized three-dimensional tissue growth in vivo.

Cronin KJ, Messina A, Thompson EW, Morrison WA, Stevens GW, Knight KR.

J Biomed Mater Res B Appl Biomater. 2007 Jul;82(1):122-8. Retraction in: Cronin KJ, Messina A, Thompson EW, Morrison WA, Stevens GW, Knight KR. J Biomed Mater Res B Appl Biomater. 2009 May;89(2):575. Erratum in: J Biomed Mater Res B Appl Biomater. 2008 Apr;85(1):300.

PMID:
17106890
33.

Survival and function of transplanted islet cells on an in vivo, vascularized tissue engineering platform in the rat: A pilot study.

Brown DL, Meagher PJ, Knight KR, Keramidaris E, Romeo-Meeuw R, Penington AJ, Morrison WA.

Cell Transplant. 2006;15(4):319-24. Retraction in: Morrison WA. Cell Transplant. 2008;16(10):1071.

PMID:
16898225
34.

Contact with existing adipose tissue is inductive for adipogenesis in matrigel.

Kelly JL, Findlay MW, Knight KR, Penington A, Thompson EW, Messina A, Morrison WA.

Tissue Eng. 2006 Jul;12(7):2041-7.

PMID:
16889532
35.

Current trends in behavioral interventions for children with autism.

Scattone D, Knight KR.

Int Rev Neurobiol. 2006;72:181-93. Review.

PMID:
16697298
36.

Survival and Function of Transplanted Islet Cells on an in Vivo, Vascularized Tissue Engineering Platform in the Rat: A Pilot Study 1.

Brown DL, Meagher PJ, Knight KR, Keramidaris E, Romeo-Meeuw R, Penington AJ, Morrison WA.

Cell Transplant. 2006 Apr;15(4):319-324. doi: 10.3727/000000006783981909.

PMID:
28863745
37.

Vascularized tissue-engineered chambers promote survival and function of transplanted islets and improve glycemic control.

Knight KR, Uda Y, Findlay MW, Brown DL, Cronin KJ, Jamieson E, Tai T, Keramidaris E, Penington AJ, Rophael J, Harrison LC, Morrison WA.

FASEB J. 2006 Mar;20(3):565-7. Epub 2006 Jan 25. Erratum in: FASEB J. 2008 May;22(5):1618.

PMID:
16436466
39.

The use of pimonidazole to characterise hypoxia in the internal environment of an in vivo tissue engineering chamber.

Hofer SO, Mitchell GM, Penington AJ, Morrison WA, RomeoMeeuw R, Keramidaris E, Palmer J, Knight KR.

Br J Plast Surg. 2005 Dec;58(8):1104-14. Epub 2005 Jul 25.

PMID:
16043148
40.

Sexual risk taking among HIV-positive injection drug users: contexts, characteristics, and implications for prevention.

Knight KR, Purcell D, Dawson-Rose C, Halkitis PN, Gomez CA; Seropositive Urban Injectors Study Team.

AIDS Educ Prev. 2005 Feb;17(1 Suppl A):76-88.

PMID:
15843119
41.

Transgenic expression of human complement regulators reduces skeletal muscle ischaemia/reperfusion injury in mice.

Knight KR, Shinkel TA, Cowan PJ, Romeo-Meeuw R, d'Apice AJ, Morrison WA.

Clin Sci (Lond). 2005 Jan;108(1):47-53. Retraction in: Morrison WA. Clin Sci (Lond). 2008 Oct;115(8):263.

PMID:
15341509
42.

New murine model of spontaneous autologous tissue engineering, combining an arteriovenous pedicle with matrix materials.

Cronin KJ, Messina A, Knight KR, Cooper-White JJ, Stevens GW, Penington AJ, Morrison WA.

Plast Reconstr Surg. 2004 Jan;113(1):260-9.

PMID:
14707645
43.
44.

Increasing the volume of vascularized tissue formation in engineered constructs: an experimental study in rats.

Hofer SO, Knight KM, Cooper-White JJ, O'Connor AJ, Perera JM, Romeo-Meeuw R, Penington AJ, Knight KR, Morrison WA, Messina A.

Plast Reconstr Surg. 2003 Mar;111(3):1186-92; discussion 1193-4.

PMID:
12621190
45.

Vascularisation of tissue-engineered grafts: the regulation of angiogenesis in reconstructive surgery and in disease states.

Cassell OC, Hofer SO, Morrison WA, Knight KR.

Br J Plast Surg. 2002 Dec;55(8):603-10. Review.

PMID:
12550111
46.

Decline in FEV1 in patients with PiZ alpha-1-antitrypsin deficiency: the Australian experience.

Burdon JG, Brenton S, Hocking V, Knight KR, Ayad M, Cook L, Janus ED.

Respirology. 2002 Mar;7(1):51-5.

PMID:
11896901
47.

The influence of extracellular matrix on the generation of vascularized, engineered, transplantable tissue.

Cassell OC, Morrison WA, Messina A, Penington AJ, Thompson EW, Stevens GW, Perera JM, Kleinman HK, Hurley JV, Romeo R, Knight KR.

Ann N Y Acad Sci. 2001 Nov;944:429-42.

PMID:
11797691
48.

Role of priming stresses and Hsp70 in protection from ischemia-reperfusion injury in cardiac and skeletal muscle.

Lepore DA, Knight KR, Anderson RL, Morrison WA.

Cell Stress Chaperones. 2001 Apr;6(2):93-6. Review.

49.

Effects of the endothelin receptor antagonist Bosentan on ischaemia/reperfusion injury in rat skeletal muscle.

Herbert KJ, Hickey MJ, Lepore DA, Knight KR, Morrison WA, Stewart AG.

Eur J Pharmacol. 2001 Jul 13;424(1):59-67.

PMID:
11470261
50.

Targeted disruption of the nitric oxide synthase 2 gene protects against ischaemia/reperfusion injury to skeletal muscle.

Barker JE, Knight KR, Romeo R, Hurley JV, Morrison WA, Stewart AG.

J Pathol. 2001 May;194(1):109-15.

PMID:
11329149

Supplemental Content

Loading ...
Support Center